 Jasmina Redzic
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basigin | 3 | 2013 | 25 | 0.880 |
Why?
| | Metalloproteases | 1 | 2022 | 37 | 0.820 |
Why?
| | Immunoglobulin A | 1 | 2022 | 166 | 0.760 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.700 |
Why?
| | RNA | 3 | 2023 | 806 | 0.520 |
Why?
| | Glioma | 2 | 2016 | 285 | 0.520 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 385 | 0.490 |
Why?
| | Extracellular Space | 1 | 2013 | 116 | 0.420 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 118 | 0.420 |
Why?
| | Mutation | 3 | 2023 | 3338 | 0.410 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 153 | 0.400 |
Why?
| | Models, Molecular | 9 | 2021 | 1368 | 0.390 |
Why?
| | Virulence Factors | 2 | 2022 | 139 | 0.370 |
Why?
| | Interleukin-6 | 1 | 2013 | 673 | 0.330 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 2 | 2020 | 20 | 0.330 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 133 | 0.310 |
Why?
| | Brain Neoplasms | 1 | 2016 | 966 | 0.310 |
Why?
| | Bacteria | 3 | 2023 | 725 | 0.300 |
Why?
| | Protein Conformation | 5 | 2021 | 803 | 0.290 |
Why?
| | Erythrocytes | 2 | 2021 | 568 | 0.270 |
Why?
| | Immune Tolerance | 2 | 2019 | 321 | 0.250 |
Why?
| | Cytochromes c | 1 | 2005 | 60 | 0.240 |
Why?
| | Extracellular Vesicles | 2 | 2016 | 83 | 0.230 |
Why?
| | Exosomes | 2 | 2015 | 92 | 0.220 |
Why?
| | Protein Domains | 2 | 2023 | 207 | 0.220 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 15 | 0.220 |
Why?
| | NAD | 1 | 2023 | 63 | 0.210 |
Why?
| | Recombinant Proteins | 3 | 2020 | 1228 | 0.210 |
Why?
| | Streptococcus | 1 | 2022 | 22 | 0.210 |
Why?
| | Interleukins | 2 | 2023 | 236 | 0.210 |
Why?
| | Thermodynamics | 2 | 2020 | 380 | 0.200 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 146 | 0.200 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2005 | 333 | 0.190 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 476 | 0.190 |
Why?
| | Immune Evasion | 1 | 2021 | 47 | 0.180 |
Why?
| | Bacterial Proteins | 3 | 2023 | 735 | 0.180 |
Why?
| | Binding Sites | 2 | 2021 | 1166 | 0.180 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 14 | 0.180 |
Why?
| | Neoplasms | 1 | 2014 | 2086 | 0.180 |
Why?
| | Serine Endopeptidases | 1 | 2020 | 101 | 0.170 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.170 |
Why?
| | Protease Inhibitors | 1 | 2020 | 96 | 0.170 |
Why?
| | Blood Donors | 1 | 2021 | 84 | 0.170 |
Why?
| | Arthritis | 1 | 2020 | 109 | 0.170 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 2700 | 0.160 |
Why?
| | Cyclophilin A | 2 | 2009 | 24 | 0.160 |
Why?
| | Prescription Drugs | 1 | 2021 | 116 | 0.160 |
Why?
| | Crystallography, X-Ray | 3 | 2020 | 402 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 590 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 532 | 0.160 |
Why?
| | Proteomics | 3 | 2016 | 815 | 0.160 |
Why?
| | Coenzymes | 1 | 2018 | 16 | 0.150 |
Why?
| | Lymph | 2 | 2009 | 31 | 0.150 |
Why?
| | Biomarkers, Tumor | 2 | 2014 | 1032 | 0.140 |
Why?
| | Evolution, Molecular | 1 | 2021 | 429 | 0.140 |
Why?
| | Proteins | 1 | 2023 | 906 | 0.140 |
Why?
| | Mass Spectrometry | 3 | 2016 | 622 | 0.140 |
Why?
| | Humans | 19 | 2023 | 114045 | 0.140 |
Why?
| | Shock, Hemorrhagic | 2 | 2009 | 152 | 0.130 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 44 | 0.130 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2016 | 24 | 0.130 |
Why?
| | Catalytic Domain | 3 | 2023 | 196 | 0.130 |
Why?
| | Huntington Disease | 1 | 2016 | 40 | 0.130 |
Why?
| | Oxidation-Reduction | 3 | 2021 | 917 | 0.120 |
Why?
| | Protein Multimerization | 2 | 2019 | 157 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2629 | 0.120 |
Why?
| | Interleukin-1 | 1 | 2019 | 965 | 0.120 |
Why?
| | Alkynes | 1 | 2014 | 53 | 0.120 |
Why?
| | Azides | 1 | 2014 | 46 | 0.120 |
Why?
| | Click Chemistry | 1 | 2014 | 48 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2023 | 474 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2019 | 720 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2013 | 68 | 0.110 |
Why?
| | Animals | 10 | 2023 | 31565 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 489 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3498 | 0.100 |
Why?
| | Cell Communication | 1 | 2014 | 277 | 0.100 |
Why?
| | Cytokines | 2 | 2020 | 1824 | 0.100 |
Why?
| | Mesentery | 2 | 2009 | 41 | 0.100 |
Why?
| | Protein Transport | 1 | 2013 | 391 | 0.100 |
Why?
| | Mammals | 2 | 2023 | 241 | 0.090 |
Why?
| | Protein Structure, Quaternary | 1 | 2011 | 115 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 847 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 802 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2464 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 373 | 0.090 |
Why?
| | Mice | 6 | 2023 | 14843 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 1981 | 0.080 |
Why?
| | Aged | 3 | 2022 | 18969 | 0.080 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 34 | 0.080 |
Why?
| | HMGB1 Protein | 1 | 2008 | 47 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2020 | 3861 | 0.080 |
Why?
| | S100 Proteins | 1 | 2008 | 37 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 8 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1735 | 0.070 |
Why?
| | Protein Folding | 1 | 2009 | 239 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 121 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2371 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2008 | 204 | 0.070 |
Why?
| | Th2 Cells | 1 | 2008 | 154 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 81 | 0.070 |
Why?
| | Keratinocytes | 1 | 2008 | 215 | 0.070 |
Why?
| | Immunologic Factors | 1 | 2008 | 217 | 0.070 |
Why?
| | Autophagy | 1 | 2008 | 235 | 0.070 |
Why?
| | Glioblastoma | 1 | 2008 | 250 | 0.060 |
Why?
| | Immunoglobulin E | 1 | 2007 | 314 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 594 | 0.060 |
Why?
| | Glycoproteins | 1 | 2007 | 304 | 0.060 |
Why?
| | Arachis | 1 | 2007 | 146 | 0.060 |
Why?
| | Enzyme Stability | 1 | 2005 | 62 | 0.060 |
Why?
| | Protein Denaturation | 1 | 2005 | 68 | 0.060 |
Why?
| | Hydrogen Bonding | 1 | 2005 | 143 | 0.060 |
Why?
| | Dermatitis, Atopic | 1 | 2008 | 307 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2005 | 261 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 345 | 0.060 |
Why?
| | Allergens | 1 | 2007 | 410 | 0.050 |
Why?
| | Peanut Hypersensitivity | 1 | 2007 | 197 | 0.050 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2019 | 238 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 24 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 17 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 19 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 79 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2023 | 81 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 51 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 29 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 74 | 0.050 |
Why?
| | Mutagenesis | 1 | 2023 | 168 | 0.050 |
Why?
| | Serine | 1 | 2023 | 125 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 66 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 347 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 236 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 47 | 0.050 |
Why?
| | Blood Banks | 1 | 2021 | 38 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 4680 | 0.050 |
Why?
| | Ranitidine | 1 | 2021 | 13 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 41 | 0.050 |
Why?
| | Hemolysis | 1 | 2021 | 143 | 0.040 |
Why?
| | Protein Binding | 2 | 2020 | 1888 | 0.040 |
Why?
| | Biocatalysis | 1 | 2020 | 58 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 191 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 77 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 570 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 142 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2020 | 353 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 224 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 123 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 541 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 161 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1003 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 77 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 308 | 0.040 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.040 |
Why?
| | NADP | 1 | 2018 | 42 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 99 | 0.040 |
Why?
| | Machine Learning | 1 | 2021 | 315 | 0.040 |
Why?
| | Ligands | 1 | 2019 | 556 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 813 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 445 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 499 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 4501 | 0.030 |
Why?
| | Huntingtin Protein | 1 | 2016 | 10 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 511 | 0.030 |
Why?
| | Neostriatum | 1 | 2016 | 29 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 727 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2015 | 55 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 314 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2562 | 0.030 |
Why?
| | Cycloaddition Reaction | 1 | 2014 | 24 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1257 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 370 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1611 | 0.030 |
Why?
| | Copper | 1 | 2014 | 99 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 179 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2009 | 2182 | 0.030 |
Why?
| | Surface Properties | 1 | 2014 | 385 | 0.030 |
Why?
| | Male | 4 | 2021 | 55396 | 0.020 |
Why?
| | Rats | 2 | 2009 | 4913 | 0.020 |
Why?
| | Syndecan-1 | 1 | 2009 | 27 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 26605 | 0.020 |
Why?
| | Static Electricity | 1 | 2009 | 112 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2008 | 51 | 0.020 |
Why?
| | beta-Defensins | 1 | 2008 | 18 | 0.020 |
Why?
| | Catalysis | 1 | 2009 | 289 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 325 | 0.020 |
Why?
| | Point Mutation | 1 | 2009 | 216 | 0.020 |
Why?
| | Protein Engineering | 1 | 2009 | 98 | 0.020 |
Why?
| | Adult | 3 | 2021 | 30375 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 2008 | 160 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2008 | 65 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2009 | 337 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 107 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 17800 | 0.020 |
Why?
| | Basophil Degranulation Test | 1 | 2007 | 5 | 0.020 |
Why?
| | 2S Albumins, Plant | 1 | 2007 | 25 | 0.020 |
Why?
| | Basophils | 1 | 2007 | 64 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2009 | 252 | 0.020 |
Why?
| | Antigens, Plant | 1 | 2007 | 46 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 134 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 796 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 121 | 0.020 |
Why?
| | Temperature | 1 | 2009 | 564 | 0.020 |
Why?
| | Mast Cells | 1 | 2007 | 116 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 318 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 613 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10444 | 0.020 |
Why?
| | Actins | 1 | 2007 | 376 | 0.020 |
Why?
| | Plant Extracts | 1 | 2007 | 154 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 907 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 1836 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1089 | 0.010 |
Why?
| | Chronic Disease | 1 | 2008 | 1577 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 3003 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1696 | 0.010 |
Why?
| | Female | 1 | 2021 | 59324 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 9114 | 0.010 |
Why?
| | Child | 1 | 2007 | 18401 | 0.000 |
Why?
|
|
Redzic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|